Proliferative and Interferon Responses by Peripheral Blood Mononuclear Cells After Bone Marrow Transplantation in Humans

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1978 Jun 1

PMID 208979

Citations 8

Authors

M J Levin

R Parkman

M N Oxman

J M Rappeport

M Simpson

P L Leary

Affiliations

Soon will be listed here.

Abstract

The capacity of peripheral blood mononuclear cells from bone marrow transplant recipients to proliferate and produce interferon in response to mitogens and specific antigens was tested. Proliferation in response to phytohemagglutinin or pokeweed mitogen occurred in cells from more than 90% of the recipients, and interferon was present in 60 to 70% of the supernatants from these cultures, even when tested as soon as 8 weeks after transplantation. Proliferation in response to bacterial antigens was infrequent, and interferon release was not detected. In the early post-transplantation period (less than 13 weeks), cells from only two of four cytomegalovirus (CMV) antibody-positive patients proliferated normally in response to CMV antigen and interferon release was detected only once. In the late post-transplantation period (more than 13 weeks), in only two of five instances did cells proliferating in response to CMV antigen release interferon. The response to CMV antigen of mononuclear cells from many transplant recipients differs from that of cells from normal controls.

Citing Articles

Characterization of innate immune viral sensors in patients following allogeneic hematopoietic stem cell transplantation.

Caddy S, Wang M, Krishnamurthy P, Uttenthal B, Chandra A, Crawley C Innate Immun. 2018; 24(2):112-121.

PMID: 29433372 PMC: 6830896. DOI: 10.1177/1753425918757898.

Antigen-specific T-lymphocyte function after cord blood transplantation.

Cohen G, Carter S, Weinberg K, Masinsin B, Guinan E, Kurtzberg J Biol Blood Marrow Transplant. 2006; 12(12):1335-42.

PMID: 17162216 PMC: 1794680. DOI: 10.1016/j.bbmt.2006.08.036.

Gamma interferon production by combinations of human peripheral blood lymphocytes, monocytes, and cultured macrophages.

Arbeit R, Leary P, Levin M Infect Immun. 1982; 35(2):383-90.

PMID: 6173323 PMC: 351050. DOI: 10.1128/iai.35.2.383-390.1982.

Inhibition of human herpesviruses by combination of acyclovir and human leukocyte interferon.

Levin M, Leary P Infect Immun. 1981; 32(3):995-9.

PMID: 6166569 PMC: 351549. DOI: 10.1128/iai.32.3.995-999.1981.

Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens.

Starr S, Dalton B, Garrabrant T, Paucker K, Plotkin S Infect Immun. 1980; 30(1):17-22.

PMID: 6160103 PMC: 551270. DOI: 10.1128/iai.30.1.17-22.1980.

References

Elfenbein G, Anderson P, Humphrey R, Mullins G, SENSENBRENNER L, Wands J . Immune system reconstitution following allogeneic bone marrow transplantation in man: a multiparameter analysis. Transplant Proc. 1976; 8(4):641-6. View

RAY C . The ontogeny of interferon production by human leukocytes. J Pediatr. 1970; 76(1):94-8. DOI: 10.1016/s0022-3476(70)80136-6. View

Neiman P, Reeves W, Ray G, Flournoy N, Lerner K, Sale G . A prospective analysis interstitial pneumonia and opportunistic viral infection among recipients of allogeneic bone marrow grafts. J Infect Dis. 1977; 136(6):754-67. DOI: 10.1093/infdis/136.6.754. View

Rand K, Rasmussen L, Pollard R, Arvin A, Merigan T . Cellular immunity and herpesvirus infections in cardiac-transplant patients. N Engl J Med. 1977; 296(24):1372-7. DOI: 10.1056/NEJM197706162962402. View

OReilly R, Chibbaro A, Anger E, Lopez C . Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. J Immunol. 1977; 118(3):1095-1102. View

Hamilton J, OVERALL J, Glasgow L . Synergistic effect on mortality in mice with murine cytomegalovirus and Pseudomonas aeruginosa, Staphylococcus aureus, or Candida albicans infections. Infect Immun. 1976; 14(4):982-9. PMC: 415482. DOI: 10.1128/iai.14.4.982-989.1976. View

Boyum A . A one-stage procedure for isolation of granulocytes and lymphocytes from human blood. General sedimentation properties of white blood cells in a 1g gravity field. Scand J Clin Lab Invest Suppl. 1968; 97:51-76. View

Rasmussen L, Jordan G, Stevens D, Merigan T . Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol. 1974; 112(2):728-36. View

Cantell K, Strander H, SAXEN L, Meyer B . Interferon response of human leukocytes during intrauterine and postnatal life. J Immunol. 1968; 100(6):1304-9. View

10.

Clift R, Buckner C, Fefer A, Lerner K, Neiman P, Storb R . Infectious complications of marrow transplantation. Transplant Proc. 1974; 6(4):389-93. View

11.

ELKINS W . Cellular immunology and the pathogenesis of graft versus host reactions. Prog Allergy. 1971; 15:78-187. View

12.

SOLBERG C, Meuwissen H, Needham R, GOOD R, Matsen J . Infectious complications in bone marrow transplant patients. Br Med J. 1971; 1(5739):18-23. PMC: 1794721. DOI: 10.1136/bmj.1.5739.18. View

13.

Camitta B, Nathan D, FORMAN E, Parkman R, Rappeport J, Orellana T . Posthepatitic severe aplastic anemia--an indication for early bone marrow transplantation. Blood. 1974; 43(4):473-83. View

14.

Epstein L, Ammann A . Evaluation of T lymphocyte effector function in immunodeficiency diseases: abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency. J Immunol. 1974; 112(2):617-26. View

15.

Kleinerman E, Snyderman R, Daniels C . Depression of human monocyte chemotaxis by herpes simplex and influenza viruses. J Immunol. 1974; 113(5):1562-7. View

16.

Merigan T . Host defenses against viral disease. N Engl J Med. 1974; 290(6):323-9. DOI: 10.1056/NEJM197402072900608. View

17.

Merigan T, Stevens D . Viral infections in man associated with acquired immunological deficiency states. Fed Proc. 1971; 30(6):1858-64. View

18.

Allison A . Immunity and immunopathology in virus infections. Ann Inst Pasteur (Paris). 1972; 123(4):585-608. View

19.

Ennis F . Host defense mechanisms against Herpes simplex virus. I. Control of infection in vitro by senstized spleen cells and antibody. Infect Immun. 1973; 7(6):898-904. PMC: 422780. DOI: 10.1128/iai.7.6.898-904.1973. View

20.

Ennis F . Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells. J Infect Dis. 1973; 127(6):632-8. DOI: 10.1093/infdis/127.6.632. View